Related references
Note: Only part of the references are listed.Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency
Benedicte Neven et al.
BLOOD (2009)
Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection
Robert E. Throm et al.
BLOOD (2009)
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
Eugenio Montini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Self-inactivating Retroviral Vector-mediated Gene Transfer Induces Oncogene Activation and Immortalization of Primary Murine Bone Marrow Cells
Marita Bosticardo et al.
MOLECULAR THERAPY (2009)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Salima Hacein-Bey-Abina et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency
Susannah I. Thornhill et al.
MOLECULAR THERAPY (2008)
Physiological promoters reduce the genotoxic risk of integrating gene vectors
Daniela Zychlinski et al.
MOLECULAR THERAPY (2008)
Combinatorial Incorporation of Enhancer-Blocking Components of the Chicken beta-Globin 5 ' HS4 and Human T-Cell Receptor alpha/delta BEAD-1 Insulators in Self-Inactivating Retroviral Vectors Reduces Their Genotoxic Potential
Ali Ramezani et al.
STEM CELLS (2008)
An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation
Byoung Y. Ryu et al.
BLOOD (2008)
Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells
Fang Zhang et al.
BLOOD (2007)
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo
Kerstin Schwarzwaelder et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency
Javier Chinen et al.
BLOOD (2007)
Gene therapy for severe combined immunodeficiency: are we there yet?
Marina Cavazzana-Calvo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Importance of murine study design for testing toxicity of retroviral vectors in support of phase trials
Elke Will et al.
MOLECULAR THERAPY (2007)
Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects
Mari Aker et al.
HUMAN GENE THERAPY (2007)
Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer
Gustavo Mostoslavsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity
Ute Modlich et al.
BLOOD (2006)
Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy
Yan Shou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells
A Schambach et al.
MOLECULAR THERAPY (2006)
Bone marrow transplantation for severe combined immune deficiency
E Grunebaum et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion
CC Zhang et al.
BLOOD (2005)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
HB Gaspar et al.
LANCET (2004)
Cytokines and immunodeficiency diseases:: critical roles of the γc-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways
PE Kovanen et al.
IMMUNOLOGICAL REVIEWS (2004)
Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system
H Hanawa et al.
BLOOD (2004)
Extended β-globin locus control region elements promote consistent therapeutic expression of a γ-globin lentiviral vector in murine β-thalassemia
H Hanawa et al.
BLOOD (2004)
Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution
RH Buckley
ANNUAL REVIEW OF IMMUNOLOGY (2004)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:: report of the European experience 1968-99
C Antoine et al.
LANCET (2003)
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
C May et al.
NATURE (2000)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)
Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy
M Otsu et al.
MOLECULAR THERAPY (2000)
Share Paper
